As biologics gain greater prominence, protein engineers are adapting to new indications, new advances in targeting science, new product formats, and products that are truly differentiated in the marketplace. The Protein Engineering & Development pipeline offers a weeklong exploration of state-of-the-art approaches for developing safe and effective protein and antibody-based therapeutics, including improving product qualities, optimizing lead and candidate selection, and the application of deep sequencing and single cell analysis.
Recombinant Protein Therapeutics
( 重组蛋白质疗法 )
Lead and Candidate Selection for Therapeutic Proteins
( 治疗用蛋白质的先导化合物和药剂候补选择 )
Deep Sequencing and Single Cell Analysis for Antibody Discovery
( 抗体发现的深度定序和单一细胞解析 )